Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03382938 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dexmedetomidine Wound Infiltration in Cesarean Section

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 19, 2025 (before its estimated December 20, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 22, 2024 to Dec 20, 2025
    • Study completion date: Feb 2025 to Nov 20, 2026
    v10
  2. Primary completion date: Dec 22, 2023 to Dec 22, 2024
    • Study completion date: Feb 2024 to Feb 2025
    v9
  3. Primary completion date: Dec 22, 2022 to Dec 22, 2023
    • Study completion date: Aug 2023 to Feb 2024
    v8
  4. Primary completion date: Apr 2022 to Dec 22, 2022
    • Study completion date: Dec 2022 to Aug 2023
    v7
  5. Trial status: Active, Not Recruiting to Recruiting
    • Primary completion date: Apr 2021 to Apr 2022
    • Study completion date: Dec 2021 to Dec 2022
    • Site details revised
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Jul 2020 to Apr 2021
    • Start date: Jan 23, 2018 to Aug 23, 2019
    • Study completion date: Dec 2020 to Dec 2021
    v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jan 2020 to Jul 2020
    • Study completion date: May 2020 to Dec 2020
    • Site details revised
    v4
  3. Primary completion date: Jan 2019 to Jan 2020
    • Study completion date: May 2019 to May 2020
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2018 to Jan 23, 2018
    • Study site revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).
Trial Details
NCT Number NCT03382938
Lead Sponsor Attikon Hospital
Conditions
(from sponsor)		 Postoperative Pain
Related terms Postoperative Pain
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov